SignIn
Kerala Kaumudi Online
Sunday, 24 January 2021 2.33 AM IST

Serum Institute rejects charges levelled by vaccine trial participant, threatens to seek damages

covid-vaccine

NEW DELHI: Vaccine major Serum Institute of India on Sunday rejected charges that a COVID-19 vaccine candidate has serious side effects, and threatened to seek heavy damages for "malicious" allegations.
A 40-year-old man who took part in the ''Covidshield'' vaccine trial in Chennai has alleged serious side effects, including a virtual neurological breakdown and impairment of cognitive functions and has sought Rs 5 crore compensation in a legal notice to Serum Institute and others, besides seeking a halt to the trial.

"The allegations in the notice are malicious and misconceived. While the Serum Institute of India is sympathetic with the volunteer's medical condition, there is absolutely no correlation with the vaccine trial and the medical condition of the volunteer," Serum Institute of India said in a statement.

The volunteer is falsely laying the blame for his medical problems on the COVID vaccine trial, it added.

"It is evident that the intention behind the spreading of such malicious information is an oblique pecuniary motive. The Serum Institute of India, will seek damages in excess of 100 crores for the same and will defend such malicious claims," Serum Institute said.

Pune-based Serum Institute of India (SII) has collaborated with Oxford University and pharmaceutical company Astra Zeneca for making the COVID-19 vaccine, 'Covidshield', and is conducting trials in India.

JOIN THE DISCUSSION
TAGS: SERUM INSTITUTE OF INDIA, COVID VACCINE, VACCINE, COVIDSHIELD
KERALA KAUMUDI EPAPER
TRENDING IN INDIA
TRENDING IN INDIA
X
Lorem ipsum dolor sit amet
consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
We respect your privacy. Your information is safe and will never be shared.